Download PDF
CC BY-NC-ND 4.0 · Neurology International Open 2018; 2(02): 131-135
DOI: 10.1055/a-0621-8559
Original Paper
Eigentümer und Copyright ©Georg Thieme Verlag KG 2018

The General and Social Health Long-Term Outcome of Adult Epilepsy Patients at the Kork Epilepsy Center

Maxi Burkhardt
1   Kork Epilepsy Center, Kehl-Kork, Germany
,
Matthias Bacher
1   Kork Epilepsy Center, Kehl-Kork, Germany
,
Reinhold Kornmeier
1   Kork Epilepsy Center, Kehl-Kork, Germany
,
Christoph Kurth
1   Kork Epilepsy Center, Kehl-Kork, Germany
,
Anke M. Staack
1   Kork Epilepsy Center, Kehl-Kork, Germany
,
Bernhard J. Steinhoff
1   Kork Epilepsy Center, Kehl-Kork, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
14 May 2018 (online)

   Permissions and Reprints

Abstract

Objectives The majority of epidemiological studies show that there is an increased burden of somatic comorbidities among people with epilepsy (PWE) compared with the general population. We sought that in the subgroup of patients with satisfactory and stable seizure situation and healthy style of living, the general health and quality of life might be similar to people without epilepsy and investigated the long-term outcome and the prevalence of comorbidities and the social outcome of adult patients who had been continuously treated at our center for at least 25 years.

Material and methods We consecutively collected our adult out-patients for 10 months and identified those patients who had been treated at our center for at least 25 years. Among this group we assessed demographic data, epilepsy syndrome, seizure situation, antiepileptic therapy, the number of previous AEDs, the socioeconomic situation and co-morbidities.

Results Out of a total of 1672 patients, 14.4 % (n = 241) patients fulfilled our inclusion criterion. In 200 the files allowed an appropriate analysis of the data. Mean treatment duration in Kork was 36 years (25 – 52). 60% of patients were seizure-free for more than one year. 80% of the seizure-free patients did not complain of adverse events. Adverse events were more often among patients with ongoing seizures. Somnolence, gait disturbances and tremor were the leading symptoms. Better seizure outcome correlated with higher education, better professional education and lower unemployment rates. Diseases such as cardiovascular diseases or diabetes mellitus were not more frequent than in the general population. PWE do not have necessarily an impaired prognosis of their general health.

Keywords

cross-sectional - epilepsy - long-term - quality of life
 

  • References

  • 1 Beghi E. Addressing the burden of epilepsy: Many unmet needs. Pharmacol Res 2016; 107: 79-84
    CrossrefPubMedGoogle Scholar
  • 2 Forsgren L, Beghi E, Oun A. et al. The epidemiology of epilepsy in Europe – a systematic review. Eur J Neurol 2005; 12: 245-253
    CrossrefPubMedGoogle Scholar
  • 3 Gilliam FG, Mendiratta A, Pack AM. et al. Epilepsy and common comorbidities: Improving the outpatient epilepsy encounter. Epileptic Disord 2005; 7 Suppl1 S27-S33
    PubMedGoogle Scholar
  • 4 Schmidt D. Pharmacotherapy of epilepsy – current problems and controversies. Fortschr Neurol Psychiatr 1983; 51: 363-386
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319
    CrossrefPubMedGoogle Scholar
  • 6 Shorvon SD, Goodridge DM. Longitudinal cohort studies of the prognosis of epilepsy: Contributions of the National General Practice Study of Epilepsy and other studies. Brain 2013; 136: 3497-3510
    CrossrefPubMedGoogle Scholar
  • 7 Steinhoff BJ, Staack AM, Hillenbrand BC. Randomized controlled antiepileptic drug trials miss almost all patients with ongoing seizures. Epilepsy Behav 2017; 66: 45-48
    CrossrefPubMedGoogle Scholar
  • 8 Serkedaki A, Novy J. Somatic comorbidities in epilepsy. Epileptologie 2017; 34: 133-144
    PubMedGoogle Scholar
  • 9 Neligan A, Bell GS, Johnson AL. et al. The long-term risk of premature mortality in people with epilepsy. Brain 2011; 134: 388-395
    CrossrefPubMedGoogle Scholar
  • 10 Steinhoff BJ. The debate: Treatment after the first seizure – the contra. Seizure 2017; 49: 92-94
    CrossrefPubMedGoogle Scholar
  • 11 Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: Need for monitoring, treatment and prevention strategies. J Family Med Prim Care 2016; 5: 248-253
    CrossrefPubMedGoogle Scholar
  • 12 Mintzer S, Skidmore CT, Sperling MR. B-vitamin deficiency in patients treated with antiepileptic drugs. Epilepsy Behav 2012; 24: 341-344
    CrossrefPubMedGoogle Scholar
  • 13 Tomson T, Steinhoff BJ. Principles of drug treatment in adults. Handb Clin Neurol 2012; 108: 683-698
    PubMedGoogle Scholar
  • 14 Svalheim S, Sveberg L, Mochol M. et al. Interactions between antiepileptic drugs and hormones. Seizure 2015; 28: 12-17
    CrossrefPubMedGoogle Scholar
  • 15 Steinhoff BJ, Staack AM, Wisniewski I. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre. Epileptic Disord 2012; 14: 379-387
    PubMedGoogle Scholar
  • 16 Annegers JF, Hauser WA, Elveback LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979; 20: 729-737
    CrossrefPubMedGoogle Scholar
  • 17 Bell GS, Neligan A, Giavasi C. et al. Outcome of seizures in the general population after 25 years: A prospective follow-up, observational cohort study. J Neurol Neurosurg Psychiatry 2016; 87: 843-850
    CrossrefPubMedGoogle Scholar
  • 18 Beume LA, Steinhoff BJ. Long-term outcome of difficult-to-treat epilepsy in childhood. Neuropediatrics 2010; 41: 135-139
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: A population-based study. Epilepsia 2007; 48: 1128-1132
    CrossrefPubMedGoogle Scholar
  • 20 Camfield PR, Camfield CS. What happens to children with epilepsy when they become adults? Some facts and opinions. Pediatr Neurol 2014; 51: 17-23
    CrossrefPubMedGoogle Scholar
  • 21 Giussani G, Canelli V, Bianchi E. et al. Long-term prognosis of epilepsy, prognostic patterns and drug resistance: A population-based study. Eur J Neurol 2016; 23: 1218-1227
    CrossrefPubMedGoogle Scholar
  • 22 Semah F, Picot MC, Adam C. et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology 1998; 51: 1256-1262
    CrossrefPubMedGoogle Scholar
  • 23 Sillanpää M, Saarinen M, Schmidt D. Clinical conditions of long-term cure in childhood-onset epilepsy: A 45-year follow-up study. Epilepsy Behav 2014; 37: 49-53
    CrossrefPubMedGoogle Scholar
  • 24 Sillanpää M, Schmidt D, Saarinen MM. et al. Remission in epilepsy: How long is enough?. Epilepsia 2017; 58: 901-906
    CrossrefPubMedGoogle Scholar
  • 25 Camfield C, Camfield P, Smith B. Poor versus rich children with epilepsy have the same clinical course and remission rates but a less favorable social outcome: A population-based study with 25 years of follow-up. Epilepsia 2016; 57: 1826-1833
    CrossrefPubMedGoogle Scholar
  • 26 Hinnell C, Williams J, Metcalfe A. et al. Health status and health-related behaviors in epilepsy compared to their chronic conditions – A national population-based study. Epilepsia 2010; 51: 853-861
    CrossrefPubMedGoogle Scholar
  • 27 Heaney DC, Macdonald BK, Everitt A. et al. Socioeconomic variation in incidenceof epilepsy: Prospective community based study in south east England. BMJ 2002; 325: 1013-1016
    CrossrefPubMedGoogle Scholar
  • 28 Hesdorffer DC, Tian H, Anand K. et al. Socioeconomic status is a risk factor for epilepsy in icelandic adults but not in children. Epilepsia 2005; 46: 1297-1303
    CrossrefPubMedGoogle Scholar
  • 29 Kaiboriboon K, Bakaki PM, Lhatoo SD. et al. Incidence and prevalence of treated epilepsy among poor health and low-income Americans. Neurology 2013; 80: 1942-1949
    CrossrefPubMedGoogle Scholar
  • 30 Martin A, Ford T, Goodman R. et al. Physical illness in looked-after children: A cross-sectional study. Arch Dis Child 2014; 99: 103-107
    CrossrefPubMedGoogle Scholar
  • 31 Li X, Sundquist J, Zöller B. et al. Neighborhood, family, and childhood and adolescent epilepsy: A nationwide epidemiological study from Sweden. Seizure 2013; 23: 62-68
    PubMedGoogle Scholar
  • 32 Reilly C, Neville BGR. Academic achievement in children with epilepsy: A review. Epilepsy Res 2011; 97: 112-123
    CrossrefPubMedGoogle Scholar
  • 33 Reiter SF, Veiby G, Daltveit A-K. et al. Psychiatric comorbidity and social aspects in pregnant women with epilepsy – The Norwegian Mother and Child Cohort Study. Epilepsy Behav 2013; 29: 379-385
    CrossrefPubMedGoogle Scholar
  • 34 Hart YM, Shorvon SD. The nature of epilepsy in the general population. I. Characteristics of patients receiving medication for epilepsy. Epilepsy Res 1995; 21: 43-49
    CrossrefPubMedGoogle Scholar
  • 35 Novy J, Castelao E, Preisig M. et al. Psychiatric comorbidities and cardiovascular risk factors in patients with lifetime history of epilepsy of an urban community. Clin Neurol Neurosurg 2012; 114: 26-30
    CrossrefPubMedGoogle Scholar
  • 36 Chen J, Zhang Y, Hong Z. et al. Marital adjustment for patients with epilepsy in China. Epilepsy Behav 2013; 28: 99-103
    CrossrefPubMedGoogle Scholar
  • 37 Wada K, Iwasa H, Okada M. et al. Marital status of patients with epilepsy with special reference to the influence of epileptic seizures on the patient´s married life. Epilepsia 2004; 45: 33-36
    CrossrefPubMedGoogle Scholar
  • 38 Kariuki SM, Matuja W, Akpalu A. et al. Clinical features, proximate causes, and consequences of active convulsive epilepsy in Africa. Epilepsia 2014; 55: 76-85
    CrossrefPubMedGoogle Scholar
  • 39 Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: Effect of past treatment history. Neurology 2008; 70: 54-65
    CrossrefPubMedGoogle Scholar
  • 40 Novy J, Bell GS, Peacock GL. et al. Epilepsy as a systemic condition. Link with somatic comorbidities. Acta Neurol Scand 2017; 136: 352-359
    PubMedGoogle Scholar
  • 41 Robert-Koch Institut (Ed). Daten und Fakten: Ergebnisse der Studie "Gesundheit in Deutschland aktuell 2012". Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: RKI; 2012
    Google Scholar
  • 42 Zaccara G, Giovanelli F, Giorgi FS. et al. Tolerability of new antiepileptic drugs: A network meta-analysis. Eur J Clin Pharmacol 2017; 73: 811-817
    CrossrefPubMedGoogle Scholar
  • 43 Saraswati N, Nayak C, Sinha S. et al. Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study. Epilepsy Behav 2017; 66: 34-38
    CrossrefPubMedGoogle Scholar
  • 44 Helmstaedter C, Witt JA. Clinical neuropsychology in epilepsy: Theoretical and practical issues. Handb Clin Neurol 2012; 107: 437-459
    PubMedGoogle Scholar
  • 45 Yaghini O, Tonekaboni SH, Amir Shahkarami SM. et al. Bone mineral density in ambulatory children with epilepsy. Indian J Pediatr 2015; 82: 225-229
    CrossrefPubMedGoogle Scholar
  • 46 Ottman R, Lipton RB, Ettinger AB. et al. Comorbidities of epilepsy: Results from the Epilepsy and Comorbidities and Health (EPIC) survey. Epilepsia 2011; 52: 308-315
    CrossrefPubMedGoogle Scholar